Health Care & Life Sciences » Biotechnology | Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
998.40
307.00
300.70
229.20
545.20
600.10
Cost of Goods Sold (COGS) incl. D&A
650.20
1,720.70
2,008.60
1,964.90
1,891.20
-
Gross Income
348.30
1,413.70
1,708.00
1,735.60
1,346.00
-
SG&A Expense
4,610.00
17,715.50
28,459.70
28,491.10
59,742.20
71,360.70
EBIT
-
19,353.40
30,167.70
30,226.80
61,088.30
72,789.10
Unusual Expense
6,162.80
1,013.90
6,094.90
732.70
31,705.20
13,207.70
Non Operating Income/Expense
3,565.20
127.00
203.40
59.60
445.20
86.80
Interest Expense
106.10
33.10
-
-
-
-
Pretax Income
6,962.30
18,427.80
23,805.30
30,864.10
91,888.70
83,014.40
Income Tax
4,219.40
42.00
-
-
-
94.60
Consolidated Net Income
2,742.90
18,385.90
23,805.30
30,864.10
91,888.70
83,109
Net Income
2,742.90
18,385.90
23,805.30
30,864.10
91,888.70
83,109
Net Income After Extraordinaries
2,742.90
18,385.90
23,805.30
30,864.10
91,888.70
83,109
Net Income Available to Common
2,742.90
18,385.90
23,805.30
30,864.10
91,888.70
83,109
EPS (Basic)
0.43
0.63
0.74
0.87
1.19
0.98
Basic Shares Outstanding
6,344.00
29,158.00
32,154.00
35,285.00
76,918.00
84,782
EPS (Diluted)
0.43
0.63
0.74
0.87
1.19
0.98
Diluted Shares Outstanding
6,344.00
29,158.00
32,154.00
35,285.00
76,918.00
84,782
EBITDA
3,612.60
17,673.50
28,174.40
28,267.20
59,198.40
70,760.60
Other Operating Expense
-
224.20
-
-
-
-
Non-Operating Interest Income
3.10
71.80
64.00
35.80
1,349.90
2,895.60

About Aurinia Pharmaceuticals

View Profile
Address
4464 Markham Street
Victoria British Columbia V8Z 7X8
Canada
Employees -
Website http://www.auriniapharma.com
Updated 07/08/2019
Aurinia Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases particularly lupus nephritis. The company was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.